| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/06/2006 | WO2004081172A3 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 04/06/2006 | WO2004050837A3 Treatment of dna damage related disorders |
| 04/06/2006 | WO2004037974A3 Fagopyritol synthase genes and uses thereof |
| 04/06/2006 | WO2004029226A3 Methods for altering cell fate to generate t-cells specific for an antigen of interest |
| 04/06/2006 | US20060075526 UDP-glucose modifiers |
| 04/06/2006 | US20060075525 Transgenic Echinacea plants |
| 04/06/2006 | US20060075523 Abiotic stress responsive polynucleotides and polypeptides |
| 04/06/2006 | US20060075521 Method of producing and screening antibodies produced in transgenic plants |
| 04/06/2006 | US20060075520 Brittle stalk 2 polynucleotides, polypeptides and uses thereof |
| 04/06/2006 | US20060075519 Polypeptides having cellobiase activity and ploynucleotides encoding same |
| 04/06/2006 | US20060075518 Polypeptides having lipase activity and polynucleotides encoding same |
| 04/06/2006 | US20060075517 Canola cultivar NQC02CNX25 |
| 04/06/2006 | US20060075516 Canola cultivar NQC02CNX12 |
| 04/06/2006 | US20060075515 Enhanced zein reduction in transgenic corn seed |
| 04/06/2006 | US20060075512 Transgenic mice containing PAFR gene disruptions |
| 04/06/2006 | US20060075511 Muir-Torre-like syndrome in Fhit deficient mice |
| 04/06/2006 | US20060075510 Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor |
| 04/06/2006 | US20060074424 Method of treating spinal internal disk derangement |
| 04/06/2006 | US20060074423 Method of using an implant for treament of ligaments and tendons |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074228 antibody specifically binds to a polypeptide used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074224 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073595 Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy |
| 04/06/2006 | US20060073592 Methods of storing tissue matrices |
| 04/06/2006 | US20060073591 Cell culture media |
| 04/06/2006 | US20060073590 Human smooth muscle cells, endothelial cells, fibroblast cells grown and harvested; test serum concentrations of IgG and IgM antibodies; decellularize proteinaceous extracellular matrix for implant; test for reduced immunogenicity of engineered tissu by histopathologic analysis of sample in rabbits |
| 04/06/2006 | US20060073589 Rapid generation of activated mononuclear antigen presenting cells from monocytes |
| 04/06/2006 | US20060073588 Method for chondrocyte expansion with phenotype retention |
| 04/06/2006 | US20060073587 Neuronal progenitors from feeder-free human embryonic stem cell culture |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073566 Active modified hedgehog proteins |
| 04/06/2006 | US20060073558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073556 polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060073555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073554 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073546 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073520 Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| 04/06/2006 | US20060073519 Antibody specific to interleukin 18 precursor |
| 04/06/2006 | US20060073517 Post-translational modifications of proteins as regulatory switches |
| 04/06/2006 | US20060073515 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 04/06/2006 | US20060073498 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 04/06/2006 | US20060073478 Atlastin |
| 04/06/2006 | US20060073476 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/06/2006 | US20060073473 Evaluation of toxicity of a specimen used in the diagnosis of viral infection disease of sturgeon; useful in diagnosis of fish viral infections |
| 04/06/2006 | US20060073469 Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic t lymphocyte activity |
| 04/06/2006 | US20060073468 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 04/06/2006 | US20060073222 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 04/06/2006 | US20060073181 Scaffold whereby a bone and a metallic material can three dimensionally form together a stereoscopic binding layer; such as an artificial root of the tooth or an artificial joint implant, cell culture proliferation reactor in regenerative medicine engineering |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/06/2006 | US20060073160 Cloning of chicken anemia virus DNA |
| 04/06/2006 | US20060073159 Human anti-cancer immunotherapy |
| 04/06/2006 | US20060073157 Attenuated live Neospora vaccine |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073148 IL-13 binding agents |
| 04/06/2006 | US20060073147 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073139 Vaccine composition for preventing meningococcal disease |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073133 Sialoadhesin factor-3 antibodies |
| 04/06/2006 | US20060073126 Cytotoxic T lymphocyte |
| 04/06/2006 | US20060073125 Isolation and use of solid tumor stem cells |
| 04/06/2006 | US20060073124 Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue |
| 04/06/2006 | US20060073123 Adenovirus vectors for immunotherapy |
| 04/06/2006 | US20060073122 Method for activating human antigen presenting cells, activated human antigen - presenting cells, and use thereof |
| 04/06/2006 | US20060073118 Methods of activating NKT cells |
| 04/06/2006 | US20060073117 Methods and compositions for controlling hair follicle stem cell fate |
| 04/06/2006 | US20060073116 Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells |
| 04/06/2006 | US20060073095 Methods for screening antibody-producing cells on heterogeneous antigen substrates |
| 04/06/2006 | DE10326746B4 Bioreaktor in Form einer Organkopie, Verfahren zu dessen Herstellung und dessen Verwendung zur Anzucht, zur Differenzierung, zum Erhalt und/oder zur Nutzung von Zellen Bioreactor in the form of a copy element, process for its preparation and its use for cultivating, for differentiation, for maintaining and / or for the use of cells |
| 04/06/2006 | DE102004048106A1 Processing a biological material for removing a tumor cells, comprises transferring the material with an oncolytic viruses in vitro and incubating over a certain induction period |
| 04/06/2006 | CA2848573A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2582566A1 Cultivation of primate embryonic stem cells |
| 04/06/2006 | CA2582041A1 Recombinant human t2 rnase and uses thereof |
| 04/06/2006 | CA2581352A1 Methods for identifying new drug leads and new therapeutic uses for known drugs |
| 04/06/2006 | CA2580798A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 04/06/2006 | CA2580707A1 Rnai modulation of apob and uses thereof |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642970A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |